Can we manage prophylactic therapy in COVID-19 patients to prevent severe illness complications?

Many patients with COVID-19 have thromboembolic complications that worsen their prognosis. Herein, the authors propose a modified version of the CHA(2)DS(2)-VASc score, including 1 point for COVID-19, so that prophylaxis to protect against thromboembolic events would be indicated before the conditio...

Descripción completa

Detalles Bibliográficos
Autores principales: Reis, Paulo Eduardo Ocke, Lima, Marcos Cesar Braga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Angiologia e de Cirurgia Vascular (SBACV) 2020
Materias:
Innovations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202192/
https://www.ncbi.nlm.nih.gov/pubmed/34178079
http://dx.doi.org/10.1590/1677-5449.200057
_version_ 1783707931819114496
author Reis, Paulo Eduardo Ocke
Lima, Marcos Cesar Braga
author_facet Reis, Paulo Eduardo Ocke
Lima, Marcos Cesar Braga
author_sort Reis, Paulo Eduardo Ocke
collection PubMed
description Many patients with COVID-19 have thromboembolic complications that worsen their prognosis. Herein, the authors propose a modified version of the CHA(2)DS(2)-VASc score, including 1 point for COVID-19, so that prophylaxis to protect against thromboembolic events would be indicated before the condition becomes severe. The advantages of this modification would be prevention of the patient’s condition worsening due to thromboembolic problems and reduction of the likelihood of a need for intensive care and mechanical ventilation, reducing mortality.
format Online
Article
Text
id pubmed-8202192
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Sociedade Brasileira de Angiologia e de Cirurgia Vascular (SBACV)
record_format MEDLINE/PubMed
spelling pubmed-82021922021-06-24 Can we manage prophylactic therapy in COVID-19 patients to prevent severe illness complications? Reis, Paulo Eduardo Ocke Lima, Marcos Cesar Braga J Vasc Bras Innovations Many patients with COVID-19 have thromboembolic complications that worsen their prognosis. Herein, the authors propose a modified version of the CHA(2)DS(2)-VASc score, including 1 point for COVID-19, so that prophylaxis to protect against thromboembolic events would be indicated before the condition becomes severe. The advantages of this modification would be prevention of the patient’s condition worsening due to thromboembolic problems and reduction of the likelihood of a need for intensive care and mechanical ventilation, reducing mortality. Sociedade Brasileira de Angiologia e de Cirurgia Vascular (SBACV) 2020-05-20 /pmc/articles/PMC8202192/ /pubmed/34178079 http://dx.doi.org/10.1590/1677-5449.200057 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Innovations
Reis, Paulo Eduardo Ocke
Lima, Marcos Cesar Braga
Can we manage prophylactic therapy in COVID-19 patients to prevent severe illness complications?
title Can we manage prophylactic therapy in COVID-19 patients to prevent severe illness complications?
title_full Can we manage prophylactic therapy in COVID-19 patients to prevent severe illness complications?
title_fullStr Can we manage prophylactic therapy in COVID-19 patients to prevent severe illness complications?
title_full_unstemmed Can we manage prophylactic therapy in COVID-19 patients to prevent severe illness complications?
title_short Can we manage prophylactic therapy in COVID-19 patients to prevent severe illness complications?
title_sort can we manage prophylactic therapy in covid-19 patients to prevent severe illness complications?
topic Innovations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202192/
https://www.ncbi.nlm.nih.gov/pubmed/34178079
http://dx.doi.org/10.1590/1677-5449.200057
work_keys_str_mv AT reispauloeduardoocke canwemanageprophylactictherapyincovid19patientstopreventsevereillnesscomplications
AT limamarcoscesarbraga canwemanageprophylactictherapyincovid19patientstopreventsevereillnesscomplications

Ejemplares similares